Wells Fargo upgraded Tandem Diabetes to Overweight from Equal Weight with a price target of $45, up from $21.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNDM:
- Leerink upgrades Tandem Diabetes to Outperform on attractive risk/reward setup
- Tandem Diabetes upgraded to Outperform from Market Perform at Leerink
- Tandem Diabetes price target raised to $40 from $37 at Stifel
- Tandem Diabetes price target raised to $38 from $31 at Citi
- Reddit initiated, Seagate upgraded: Wall Street’s top analyst calls